mifepristone has been researched along with Cancer of Cervix in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sang, L; Wang, X; Zhao, X | 1 |
| Li, C; Ye, H | 1 |
| Chen, H; Duan, J; Zuo, F | 1 |
| Alvarez, A; García-López, P; Jurado, R; Lopez-Flores, A | 1 |
| Fjelldal, R; Moe, BT; Sager, G; Ørbo, A | 1 |
| Bartholomew, JS; Burt, DJ; Chengang, J; Garrido, F; Glenville, S; Ruiz-Cabello, F; Sarkar, S; Stanley, MA; Stern, PL | 1 |
| Kamradt, MC; Mohideen, N; Vaughan, AT | 1 |
| Auborn, K; James, C; Yuan, F | 1 |
| Bakke, O | 1 |
9 other study(ies) available for mifepristone and Cancer of Cervix
| Article | Year |
|---|---|
Mifepristone Inhibits the Migration of Cervical Cancer Cells by Inhibiting Exocrine Secretion.
Topics: Aniline Compounds; Apoptosis; Benzylidene Compounds; Blotting, Western; Cell Movement; Cell Proliferation; Cell Survival; Cytokines; Exosomes; Female; HeLa Cells; Humans; Mifepristone; Ubiquitins; Up-Regulation; Uterine Cervical Neoplasms | 2018 |
Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Female; Flow Cytometry; HeLa Cells; Hormone Antagonists; Humans; Inhibitor of Apoptosis Proteins; Mifepristone; Oncogene Proteins, Viral; Repressor Proteins; Survivin; Uterine Cervical Neoplasms | 2013 |
Mechanism of the reversal effect of mifepristone on drug resistance of the human cervical cancer cell line HeLa/MMC.
Topics: Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glucosyltransferases; HeLa Cells; Humans; Mifepristone; Proto-Oncogene Proteins c-bcl-2; Uterine Cervical Neoplasms | 2014 |
Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Hormone Antagonists; Humans; In Vitro Techniques; Mice; Mice, Nude; Mifepristone; Proto-Oncogene Proteins c-bcl-2; Tissue Distribution; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2009 |
MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).
Topics: Apoptosis; Breast Neoplasms; Cell Count; Cell Cycle; Cell Line, Tumor; Female; Humans; Mifepristone; Progesterone; Receptors, Progesterone; Uterine Cervical Neoplasms | 2010 |
Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.
Topics: Carcinoma; DNA, Viral; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Histocompatibility Antigens Class I; Hormone Antagonists; Humans; Hydrocortisone; Mifepristone; Papillomaviridae; Progesterone; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Virus Integration | 1997 |
RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells.
Topics: Apoptosis; Cell Survival; Dexamethasone; DNA-Binding Proteins; DNA, Neoplasm; Female; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Radiation Tolerance; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation; Uterine Cervical Neoplasms | 2000 |
Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone.
Topics: Carcinoma, Squamous Cell; Cell Division; Dactinomycin; Epithelial Cells; Female; Gene Expression Regulation, Viral; Hormone Antagonists; Humans; Laryngeal Neoplasms; Mifepristone; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Progesterone; Repressor Proteins; Ribonucleases; RNA, Viral; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1999 |
Antagonistic effect of glucocorticoids on retinoic acid induced growth inhibition and morphological alterations of a human cell line.
Topics: Cell Cycle; Cell Differentiation; Cell Line; Cytoskeleton; Dexamethasone; Estrenes; Female; Humans; Interphase; Microtubules; Mifepristone; Tretinoin; Uterine Cervical Neoplasms | 1986 |